An Open-Label, Single-Arm Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Early Stage Relapsing Remitting Multiple Scle
Posted Date: May 15, 2019
- Investigator: Lawrence Goldstick
- Specialties: Multiple Sclerosis, Neurology
- Type of Study: Drug
The purpose of this study is to see if ocrelizumab (study drug) will halt the worsening of the signs and symptoms of your early stage MS. Ocrelizumab is a type of drug called a monoclonal antibody. Monoclonal antibodies act like your body?s immune system and attach to certain cells in order to at
Criteria:
You Are Invited To Take Part In A Research Study (Also Known As A Clinical Trial) Of A Drug Called
Keywords:
Multiple Sclerosis, F. Hoffmann-La Roche, Ocrelizumab, Relapse Remitting
For More Information:
Melissa Gilchrist
937-535-5014
melissa.gilchrist@uchealth.com